IPSC
Century Therapeutics Inc

703
Mkt Cap
$189.67M
Volume
3.5M
52W High
$2.32
52W Low
$0.3418
PE Ratio
-6.98
IPSC Fundamentals
Price
$1.92
Prev Close
$2.17
Open
$2.13
50D MA
$0.8691
Beta
1.46
Avg. Volume
1.39M
EPS (Annual)
-$1.61
P/B
1.06
Rev/Employee
$43,926.67
Loading...
Loading...
News
all
press releases
Short Interest in Century Therapeutics, Inc. (NASDAQ:IPSC) Rises By 32.1%
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a significant growth in short interest in the month of December. As of December 31st, there was short interest totaling...
MarketBeat·3d ago
News Placeholder
More News
News Placeholder
FDA Grants Breakthrough Therapy Designation to ALKS' Narcolepsy Drug
Alkermes wins FDA Breakthrough Therapy status for alixorexton in NT1 after Vibrance-1 data shows improvement in wakefulness.
Zacks·13d ago
News Placeholder
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Century Therapeutics (IPSC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·13d ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) Insider Buys 58,060 Shares
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Chad Cowan bought 58,060 shares of the business's stock in a transaction that occurred on Monday, December 22nd. The shares were...
MarketBeat·22d ago
News Placeholder
Chad Cowan Buys 58,060 Shares of Century Therapeutics (NASDAQ:IPSC) Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) insider Chad Cowan purchased 58,060 shares of the stock in a transaction dated Monday, December 22nd. The shares were purchased at an...
MarketBeat·22d ago
News Placeholder
Century Therapeutics, Inc. (NASDAQ:IPSC) Sees Significant Decrease in Short Interest
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) was the recipient of a large drop in short interest during the month of December. As of December 15th, there was short interest totaling...
MarketBeat·26d ago
News Placeholder
Insider Buying: Century Therapeutics (NASDAQ:IPSC) CEO Purchases 52,000 Shares of Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) CEO Brent Pfeiffenberger bought 52,000 shares of the company's stock in a transaction that occurred on Friday, December 12th. The shares...
MarketBeat·1mo ago
News Placeholder
Brent Pfeiffenberger Purchases 52,000 Shares of Century Therapeutics (NASDAQ:IPSC) Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) CEO Brent Pfeiffenberger bought 52,000 shares of the stock in a transaction that occurred on Friday, December 12th. The shares were...
MarketBeat·1mo ago
News Placeholder
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Century Therapeutics (IPSC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·1mo ago
News Placeholder
Century Therapeutics (NASDAQ:IPSC) CEO Buys $17,500.00 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) CEO Brent Pfeiffenberger bought 35,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The shares were...
MarketBeat·2mo ago
<
1
2
...
>

Latest IPSC News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.